Skip to main content
MedPathMedPath Home
Clinical Trials/NCT02505152
NCT02505152
Unknown
Not Applicable

Percutaneous Transhepatic Intrahepatic Portosystemic Shunt for Treatment of Portal Vein Occlusion With Symptomatic Portal Hypertension After Splenectomy

Sun Yat-sen University1 site in 1 country50 target enrollmentOctober 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHypertension, PortalPortal Vein, Cavernous Transformation Of

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypertension, Portal
Sponsor
Sun Yat-sen University
Enrollment
50
Locations
1
Primary Endpoint
No gastrointestinal rebleeding in 1 month after interventions
Last Updated
10 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

To evaluate the values of percutaneous transhepatic intrahepatic portosystemic shunt for treatment of portal vein occlusion with symptomatic portal hypertension after splenectomy.

Registry
clinicaltrials.gov
Start Date
October 2010
End Date
December 2016
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Sun Yat-sen University
Responsible Party
Principal Investigator
Principal Investigator

Zaibo Jiang

Department of Radiology, The Third Affiliated Hospital, Sun Yat-Sen University

Sun Yat-sen University

Eligibility Criteria

Inclusion Criteria

  • •All patients with portal hypertension who have the history of splenectomy and have enough image information to confirm occlusion of portal vein

Exclusion Criteria

  • •Patients with known severe dysfunction of heart, lung, brain, kidney and other vital organs

Outcomes

Primary Outcomes

No gastrointestinal rebleeding in 1 month after interventions

Time Frame: 1 month

No gastrointestinal rebleeding in 1 month after interventions

Ascites disappear in 1 month after interventions

Time Frame: 1 month

Ascites disappear in 1 month after interventions

Secondary Outcomes

  • Whether the shunt is patent after interventions in 6 months(6 months)

Study Sites (1)

Loading locations...

Similar Trials

Recruiting
Phase 2
TIPS Plus Half-dose Donafenib in AHCC with PVTT-associated Portal HypertensionHepatocellular Carcinoma with PVTT
NCT06646198Fei Gao40
Completed
Not Applicable
Transjugular Intrahepatic Porto-systemic Shunt (TIPS) with Gore-tex® covered stent-graft versus endoscopic treatment for secondary prevention of gastro-oesophageal variceal bleeding
ISRCTN77521636Erasmus Medical Centre (The Netherlands)124
Recruiting
Not Applicable
Transjugular Intrahepatic Porto-systemic Shunt (TIPS) with Gore-tex covered stent-graft versus endoscopic treatment for acute bleeding of esophageal varices.bleeding of esophageal varicose veinsportal hypertension10019654
NL-OMON39467Erasmus MC, Universitair Medisch Centrum Rotterdam72
Not yet recruiting
Not Applicable
Transjugular Intrahepatic Porto-systemic Shunt (TIPS) with Gore-tex(R) covered stent-graft versus endoscopic treatment for secondary prevention of gastro-esophageal variceal bleeding.TIPS, endoscopic treatment, variceal bleeding(TIPS, endoscopische behandeling, varices bloedingen)
NL-OMON21706Erasmus MC, department of Radiology and Department of Gastro-enterology72
Recruiting
Not Applicable
Freiburg TIPS RegistryLiver CirrhosisPortal HypertensionNon-Cirrhotic Portal HypertensionBudd Chiari SyndromePortal Vein ThrombosisPortal Systemic Shunt
NCT05782556University Hospital Freiburg2,000